These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38273746)

  • 1.
    Zhao X; Zhao Z; Xie H; Gao W; Ye C
    Discov Med; 2024 Jan; 36(180):61-70. PubMed ID: 38273746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKK╬Á/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
    Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
    Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m
    Li X; Liu B; Wang S; Li J; Ge X
    Chin J Physiol; 2023; 66(1):43-51. PubMed ID: 36814156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
    Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W
    Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
    Hu Y; Gong C; Li Z; Liu J; Chen Y; Huang Y; Luo Q; Wang S; Hou Y; Yang S; Xiao Y
    Mol Cancer; 2022 Feb; 21(1):34. PubMed ID: 35114989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
    Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
    Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis.
    Li W; Huang G; Wei J; Cao H; Jiang G
    Mol Cell Biochem; 2023 Apr; 478(4):729-741. PubMed ID: 36070054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALKBH5 activates FAK signaling through m6A demethylation in
    Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
    Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
    [No Abstract]   [Full Text] [Related]  

  • 10. ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.
    Luo J; Yu H; Yuan Z; Ye T; Hu B
    Clin Transl Oncol; 2023 Jul; 25(7):2265-2276. PubMed ID: 36820954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALKBH5 promotes the progression of infantile hemangioma through regulating the NEAT1/miR-378b/FOSL1 axis.
    Peng K; Xia RP; Zhao F; Xiao Y; Ma TD; Li M; Feng Y; Zhou CG
    Mol Cell Biochem; 2022 May; 477(5):1527-1540. PubMed ID: 35182329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9.
    Li Y; Yan B; Wang X; Li Q; Kan X; Wang J; Sun Y; Wang P; Tian L; Liu M
    J Cell Mol Med; 2022 Jan; 26(2):385-398. PubMed ID: 34850551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
    Yang Z; Cai Z; Yang C; Luo Z; Bao X
    EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.
    Zhao Y; Hu J; Sun X; Yang K; Yang L; Kong L; Zhang B; Li F; Li C; Shi B; Hu K; Sun A; Ge J
    Clin Transl Med; 2021 May; 11(5):e402. PubMed ID: 34047466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via an m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma.
    Zhen L; Pan W
    Clin Exp Pharmacol Physiol; 2023 May; 50(5):380-392. PubMed ID: 36705046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced ALKBH5 aggravates synovial aggression and inflammation in rheumatoid arthritis by regulating the m6A modification of CH25H.
    Fan D; Geng Q; Wang B; Wang X; Xia Y; Yang L; Zhang Q; Deng T; Xu Y; Zhao H; Liu B; Lu C; Gu X; Xiao C
    Clin Immunol; 2024 Apr; 261():109929. PubMed ID: 38331303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.
    Zhang Z; Wang L; Zhao L; Wang Q; Yang C; Zhang M; Wang B; Jiang K; Ye Y; Wang S; Shen Z
    Clin Transl Med; 2022 Aug; 12(8):e940. PubMed ID: 35979628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma.
    Fu D; Si Q; Yu C; Han Z; Zang L
    Mol Carcinog; 2023 Nov; 62(11):1700-1716. PubMed ID: 37493109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the
    Zhou C; Liang Y; Zhou L; Yan Y; Liu N; Zhang R; Huang Y; Wang M; Tang Y; Ali DW; Wang Y; Michalak M; Chen XZ; Tang J
    Autophagy; 2021 Oct; 17(10):3175-3195. PubMed ID: 32972302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkylation Repair Homolog 5 Regulates N(6)-methyladenosine (m6A) Methylation of Mitsugumin 53 to Attenuate Myocardial Infarction by Inhibiting Apoptosis and Oxidative Stress.
    Li D; Li L; Dong S; Yu Y; Zhang L; Jiang S
    J Cardiovasc Pharmacol; 2024 Feb; 83(2):183-192. PubMed ID: 37989146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.